News
Ilaris: FDA Asks if Gout Symptom Relief Is Worth Infection Risks
- Author:
- Sue Sutter
Publish date: June 20, 2011
News
CDER: Avastin Breast Cancer Claim Undermines Approval Process
- Author:
- Sue Sutter
Publish date: May 17, 2011
News
FDA Revisits Old Issues for COPD Drug Indacaterol at Panel Review
- Author:
- Sue Sutter
Publish date: March 7, 2011
News
FDA Revisits Old Issues for COPD Drug Indacaterol at Panel Review
- Author:
- Sue Sutter
Publish date: March 7, 2011
News
FDA Revisits Old Issues for COPD Drug Indacaterol at Panel Review
- Author:
- Sue Sutter
Publish date: March 7, 2011
News
Cancer Drugs Have Worst Phase III Track Record
- Author:
- Sue Sutter
- Lisa Lamotta
Publish date: February 16, 2011
News
FDA Asks ODAC to Ponder Shift Away From Single-Arm Studies
- Author:
- Sue Sutter
Publish date: February 7, 2011
News
Toxicity of Vandetanib Is Expected Focus for FDA Advisory Committee
- Author:
- Sue Sutter
Publish date: December 1, 2010
News
FDA and CDC to Consider Gardasil for Anal Cancer Prevention
- Author:
- Sue Sutter
Publish date: November 16, 2010
News
FDA and CDC to Consider Gardasil for Anal Cancer Prevention
- Author:
- Sue Sutter
Publish date: November 16, 2010
News
Can CV Monitoring Warnings or REMS Restrictions Save Meridia?
- Author:
- Sue Sutter
Publish date: September 14, 2010
News
Can CV Monitoring Warnings or REMS Restrictions Save Meridia?
- Author:
- Sue Sutter
Publish date: September 14, 2010
News
Ceftaroline Data Robust Even Under New Antibiotic Efficacy Standards, FDA Says
- Author:
- Sue Sutter
- Cathy Dombrowski
Publish date: September 3, 2010
News
Ceftaroline Data Robust Even Under New Antibiotic Efficacy Standards, FDA Says
- Author:
- Sue Sutter
- Cathy Dombrowski
Publish date: September 3, 2010
News
Ceftaroline Data Robust Even Under New Antibiotic Standards
- Author:
- Sue Sutter
- Cathy Dombrowski
Publish date: September 3, 2010